NPPES file of Aug 9, 2026

Reve Purisima Shields, MD

Hematology & Oncology Physician · South Weymouth, MA

Reve Purisima Shields, MD is a hematology & oncology physician with a practice address in South Weymouth, Massachusetts, and NPI 1871719187, issued on Apr 17, 2007. Check the license (Massachusetts 247435, as entered in NPPES) on the Massachusetts Board of Registration in Medicine; the Medicare figures below come from public CMS files.

Record from CMS NPPES, file of Aug 9, 2026 · Medicare files 2023 and 2024 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1871719187
Name
Reve Purisima Shields
Credential
MD
Primary taxonomy
Hematology & Oncology Physician 207RH0003X
License number
247435 MA
Self-reported in NPPES; status is on the state search
Practice location
101 Columbian St, South Weymouth, MA 02190
Phone
(781) 624-4690
Enumerated
Apr 17, 2007
Record last updated
Nov 2, 2018 (not updated in 8 years: call before relying on the address or phone)
Fax
(401) 624-2610
Medicare enrollment
Enrolled (PECOS I20110901000514); accepts Medicare assignment
Medical or professional school
State Un Of Ny, Stony Brook School Of Dental Med, 2005
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). Enrollment, assignment, school and telehealth: CMS Doctors and Clinicians file, Aug 2026. A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 101 Columbian St

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. Jennifer Calzarette, PAPhysician Assistant1063145696
  2. Kelly Casey, CNPFamily Nurse Practitioner1720695935
  3. Lyndsay Caulfield, DNP, FNP-BCFamily Nurse Practitioner1053043117
  4. Deepak Chander, M.D.Hematology & Oncology Physician1659666261
  5. Katherine Cushing, LICSWClinical Social Worker1912484080
  6. Katelyn Dorney, MDObstetrics & Gynecology Physician1972913267

Verify Reve Purisima Shields in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersMassachusetts Board of Registration in Medicine
    Search for license 247435
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Open the Massachusetts license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

33% more Medicare Part D claims than the average hematology & oncology physician in 2024

1,163 Medicare Part D claims for 250 beneficiaries, against an average of 877 among the 10,784 providers of this specialty who prescribed in Part D. Brand-name drugs were 21% of claims. 60 claims were for opioids.

  1. Reve Shields1,163
  2. Specialty average877

Most prescribed

  1. Anastrozole176 claims
  2. Tamoxifen Citrate152 claims
  3. Letrozole59 claims
  4. Prochlorperazine Maleate45 claims
  5. Eliquis42 claims
  6. Gabapentin38 claims

Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.

The practice group's MIPS final score for 2023 (Medicare payment program): 89.4 of 100

The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.

  1. Qualityout of 100 · 30% of the final score75.4
  2. Costout of 100 · 30%72.7
  3. Promoting interoperabilityout of 100 · 25%100.0
  4. Improvement activities40 of 40 points · 15%100.0

Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).

Industry payments in 2024: $496.08

20 payments; by number, the most common kind was food and beverage; the largest payer was Pfizer Inc. The 8,560 providers of this specialty with any payment received $7,481.41 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.

  1. Reve Shields$496.08
  2. Specialty average$7,481.41

Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.

Bills Medicare through one group practice

  1. Signature Healthcare Medical Group IncBrockton, MA

Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).

Reve Purisima Shields among 461 hematology & oncology physician records in Massachusetts

Reve Purisima Shields, MD is one of 461 hematology & oncology physician records with a practice address in Massachusetts. 75% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2007, is newer than 50% of them.

  • NPI issued2007 · 50% of these records are older, 39% newer
  • In a Medicare fileYes · 75% of these records are
  • In the CMS Doctors and Clinicians fileYes · 66% of these records are
  • Graduated2005 · median 2004 among the 303 with a school on file
  • Record last updated2018 · 62% of these records were not updated in five years or more

Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RH0003X and a Massachusetts practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).

Hematology & Oncology Physician providers in Massachusetts

There are 461 hematology & oncology physician records in Massachusetts.

The 8 hematology & oncology physician records with the nearest ZIP codes

  1. Deepak Chander, M.D.South Weymouth, MA 021901659666261
  2. Meredith Faggen, M.D.S Weymouth, MA 021901215093968
  3. Shail Maingi, MDSouth Weymouth, MA 021901114183795
  4. Anne RobergeWeymouth, MA 021901639115041
  5. Michael Anderson, M.D.Weymouth, MA 021891144201534
  6. James Everett, M.D.Weymouth, MA 021891215911789
  7. Sarah May, M.D.Weymouth, MA 021891801879002
  8. Paul Musto, M.D.Weymouth, MA 021891699758896

Common questions

What is Reve Purisima Shields, MD's NPI number?

Reve Purisima Shields, MD's National Provider Identifier (NPI) is 1871719187, issued on Apr 17, 2007. An NPI identifies a provider in billing; it is not a license.

Where is Reve Purisima Shields, MD located?

The NPPES record lists a practice address at 101 Columbian St, South Weymouth, MA, 02190. Phone: (781) 624-4690. Providers update this record themselves, so call before visiting.

How can I verify Reve Purisima Shields, MD's license?

NPPES lists Massachusetts license number 247435, as entered by the provider. Search the Massachusetts Board of Registration in Medicine at https://findmydoctor.mass.gov/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.

How much does Reve Purisima Shields, MD prescribe under Medicare Part D?

In 2024, Reve Purisima Shields, MD had 1,163 Medicare Part D claims for 250 beneficiaries; the average among hematology & oncology physician prescribers was 877. Part D covers Medicare prescriptions only.

What is Reve Purisima Shields, MD's MIPS final score?

The 2023 MIPS final score is 89.4 of 100, reported for the practice group. The average among 454,083 clinicians with a measured score was 83.5.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.